Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Real-World Treatment Trends in Endovascular Stroke Therapy.

Saber H, Navi BB, Grotta JC, Kamel H, Bambhroliya A, Vahidy FS, Chen PR, Blackburn S, Savitz SI, McCullough L, Sheth SA.

Stroke. 2019 Feb 6:STROKEAHA118023967. doi: 10.1161/STROKEAHA.118.023967. [Epub ahead of print]

PMID:
30726185
2.

Effect of revascularization on cognitive outcomes in intracranial steno-occlusive disease: a systematic review.

Kolb B, Fadel H, Rajah G, Saber H, Luqman A, Rangel-Castilla L.

Neurosurg Focus. 2019 Feb 1;46(2):E14. doi: 10.3171/2018.11.FOCUS18517.

PMID:
30717064
3.

Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke.

Sadeghi M, Saber H, Singh A, Hanni C, Parker D, Desai A, Mohamed W.

J Stroke Cerebrovasc Dis. 2019 Jan 22. pii: S1052-3057(19)30005-9. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.005. [Epub ahead of print]

PMID:
30683492
4.

Knowledge and practice about the foot care and the prevalence of the neuropathy among a sample of type 2 diabetic patients in Erbil, Iraq.

Saber HJ, Daoud AS.

J Family Med Prim Care. 2018 Sep-Oct;7(5):967-974. doi: 10.4103/jfmpc.jfmpc_163_18.

5.

Stent Survival and Stent-Adjacent Stenosis Rates following Venous Sinus Stenting for Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis.

Saber H, Lewis W, Sadeghi M, Rajah G, Narayanan S.

Interv Neurol. 2018 Oct;7(6):490-500. doi: 10.1159/000490578. Epub 2018 Jul 31. Review.

7.

Impact of expanding large vessel occlusion thrombectomy time-windows in inner city Detroit.

Rajah GB, Saber H, Luqman A, Narayanan S.

Brain Circ. 2018 Apr-Jun;4(2):76-78. doi: 10.4103/bc.bc_9_18. Epub 2018 Jun 29. No abstract available.

8.

Intravascular imaging in neuroendovascular surgery: a brief review.

Saber H, Rajah GB, Seraji-Bozorgzad N, Nasiriavanaki M.

Neurol Res. 2018 Oct;40(10):892-899. doi: 10.1080/01616412.2018.1493972. Epub 2018 Sep 24. Review.

PMID:
30247097
9.

Antiplatelet therapy and the risk of ischemic and hemorrhagic complications associated with Pipeline embolization of cerebral aneurysms: a systematic review and pooled analysis.

Saber H, Kherallah RY, Hadied MO, Kazemlou S, Chamiraju P, Narayanan S.

J Neurointerv Surg. 2018 Sep 10. pii: neurintsurg-2018-014082. doi: 10.1136/neurintsurg-2018-014082. [Epub ahead of print]

PMID:
30201813
10.

Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.

Saber H, Desai A, Palla M, Mohamed W, Seraji-Bozorgzad N, Ibrahim M.

J Stroke Cerebrovasc Dis. 2018 Nov;27(11):2979-2985. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.027. Epub 2018 Aug 6. Review.

PMID:
30093204
11.

Endovascular delivery of leads and stentrodes and their applications to deep brain stimulation and neuromodulation: a review.

Rajah G, Saber H, Singh R, Rangel-Castilla L.

Neurosurg Focus. 2018 Aug;45(2):E19. doi: 10.3171/2018.4.FOCUS18130.

PMID:
30064310
12.

Desertification Sensitivity Analysis Using MEDALUS Model and GIS: A Case Study of the Oases of Middle Draa Valley, Morocco.

Lamqadem AA, Pradhan B, Saber H, Rahimi A.

Sensors (Basel). 2018 Jul 11;18(7). pii: E2230. doi: 10.3390/s18072230.

13.

Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice.

Dorvash MR, Khoshnood MJ, Saber H, Dehghanian A, Mosaddeghi P, Firouzabadi N.

Eur J Pharmacol. 2018 Aug 15;833:165-172. doi: 10.1016/j.ejphar.2018.06.002. Epub 2018 Jun 5.

PMID:
29883669
14.

Network meta-analysis of patent foramen ovale management strategies in cryptogenic stroke.

Saber H, Palla M, Kazemlou S, Azarpazhooh MR, Seraji-Bozorgzad N, Behrouz R.

Neurology. 2018 Jul 3;91(1):e1-e7. doi: 10.1212/WNL.0000000000005736. Epub 2018 Jun 6.

PMID:
29875222
15.

Bilateral Venous Sinus Stenosis: Idiopathic Intracranial Hypertension and Endovascular Venous Sinus Stenting: 2-Dimensional Operative Video.

Rajah G, Saber H, Luqman A, Mittal S, Narayanan S.

Oper Neurosurg (Hagerstown). 2018 Sep 1;15(3):357. doi: 10.1093/ons/opx298. No abstract available.

PMID:
29444263
16.

Prophylactic Low-Dose Oxygen for Patients With Acute Stroke.

Saber H, Moein HR, Rajamani K.

JAMA. 2018 Feb 6;319(5):501-502. doi: 10.1001/jama.2017.20342. No abstract available.

PMID:
29411026
17.

A Review of Staphylococcal Cassette Chromosome mec (SCCmec) Types in Coagulase-Negative Staphylococci (CoNS) Species.

Saber H, Jasni AS, Jamaluddin TZMT, Ibrahim R.

Malays J Med Sci. 2017 Oct;24(5):7-18. doi: 10.21315/mjms2017.24.5.2. Epub 2017 Oct 26. Review.

18.

Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis.

Palla M, Saber H, Konda S, Briasoulis A.

Integr Blood Press Control. 2018 Jan 5;11:11-24. doi: 10.2147/IBPC.S128947. eCollection 2018. Review.

19.

Comparison of the efficacy and safety of thrombectomy devices in acute stroke : a network meta-analysis of randomized trials.

Saber H, Rajah GB, Kherallah RY, Jadhav AP, Narayanan S.

J Neurointerv Surg. 2018 Aug;10(8):729-734. doi: 10.1136/neurintsurg-2017-013544. Epub 2017 Dec 15.

PMID:
29246906
20.

Long-Term Outcomes of Ischemic Stroke of Undetermined Mechanism: A Population-Based Prospective Cohort.

Morovatdar N, Thrift AG, Kapral MK, Behrouz R, Saber H, Amiri A, Farzadfard MT, Mokhber N, Stranges S, Azarpazhooh MR.

Neuroepidemiology. 2017;49(3-4):160-164. doi: 10.1159/000482019. Epub 2017 Nov 21.

PMID:
29161693
21.

Mechanical thrombectomy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery: a meta-analysis.

Saber H, Narayanan S, Palla M, Saver JL, Nogueira RG, Yoo AJ, Sheth SA.

J Neurointerv Surg. 2018 Jul;10(7):620-624. doi: 10.1136/neurintsurg-2017-013515. Epub 2017 Nov 10.

PMID:
29127196
22.

The Incidence and Characteristics of Stroke in Urban-Dwelling Iranian Women.

Amiri A, Kapral MK, Thrift AG, Sposato LA, Saber H, Behrouz R, Erfanian M, Farzadfard MT, Mokhber N, Azarpazhooh MR.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):547-554. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.050. Epub 2017 Oct 31.

PMID:
29100858
23.

An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection.

Saber H, Del Valle P, Ricks TK, Leighton JK.

Regul Toxicol Pharmacol. 2017 Nov;90:144-152. doi: 10.1016/j.yrtph.2017.09.001. Epub 2017 Sep 5. Review.

PMID:
28887049
24.

Sargassum muticum and Jania rubens regulate amino acid metabolism to improve growth and alleviate salinity in chickpea.

Abdel Latef AAH, Srivastava AK, Saber H, Alwaleed EA, Tran LP.

Sci Rep. 2017 Sep 5;7(1):10537. doi: 10.1038/s41598-017-07692-w.

25.

Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts.

Saber H, Yakoob MY, Shi P, Longstreth WT Jr, Lemaitre RN, Siscovick D, Rexrode KM, Willett WC, Mozaffarian D.

Stroke. 2017 Oct;48(10):2678-2685. doi: 10.1161/STROKEAHA.117.018235. Epub 2017 Aug 22.

26.

Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran.

Saber HR, Tabatabaee SM, Abasian A, Jamali M, SalekMoghadam E, Hajibeigi B, Alavian SM, Mirrezaie SM.

Indian J Hematol Blood Transfus. 2017 Sep;33(3):412-416. doi: 10.1007/s12288-016-0732-5. Epub 2016 Oct 1.

27.

Epidemiology of Intracranial and Extracranial Large Artery Stenosis in a Population-Based Study of Stroke in the Middle East.

Saber H, Amiri A, Thrift AG, Stranges S, Bavarsad Shahripour R, Farzadfard MT, Mokhber N, Behrouz R, Azarpazhooh MR.

Neuroepidemiology. 2017;48(3-4):188-192. doi: 10.1159/000479519. Epub 2017 Aug 11.

PMID:
28796991
28.

Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke: The Framingham Study.

Saber H, Himali JJ, Beiser AS, Shoamanesh A, Pikula A, Roubenoff R, Romero JR, Kase CS, Vasan RS, Seshadri S.

Stroke. 2017 Jul;48(7):1760-1765. doi: 10.1161/STROKEAHA.116.016563. Epub 2017 Jun 8.

29.

Clinical Development of Cancer Drugs in Combination With External Beam Radiation Therapy: US Food and Drug Administration Perspective.

Walker AJ, Kim H, Saber H, Kluetz PG, Kim G, Pazdur R.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):5-7. doi: 10.1016/j.ijrobp.2016.12.037. No abstract available.

PMID:
28587052
30.

Incidence, recurrence, and long-term survival of ischemic stroke subtypes: A population-based study in the Middle East.

Saber H, Thrift AG, Kapral MK, Shoamanesh A, Amiri A, Farzadfard MT, Behrouz R, Azarpazhooh MR.

Int J Stroke. 2017 Oct;12(8):835-843. doi: 10.1177/1747493016684843. Epub 2017 Jan 3.

PMID:
28043215
31.

An FDA oncology analysis of immune activating products and first-in-human dose selection.

Saber H, Gudi R, Manning M, Wearne E, Leighton JK.

Regul Toxicol Pharmacol. 2016 Nov;81:448-456. doi: 10.1016/j.yrtph.2016.10.002. Epub 2016 Oct 13.

PMID:
27743776
32.

Role of emergent chest radiography in evaluation of hyperacute stroke.

Saber H, Silver B, Santillan A, Azarpazhooh MR, Misra V, Behrouz R.

Neurology. 2016 Aug 23;87(8):782-5. doi: 10.1212/WNL.0000000000002964. Epub 2016 Jul 13.

PMID:
27412145
33.

Increasing thermal stability and catalytic activity of glutamate decarboxylase in E. coli: An in silico study.

Tavakoli Y, Esmaeili A, Saber H.

Comput Biol Chem. 2016 Oct;64:74-81. doi: 10.1016/j.compbiolchem.2016.05.006. Epub 2016 May 31.

PMID:
27294557
34.

An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs.

Leighton JK, Saber H, Reaman G, Pazdur R.

Regul Toxicol Pharmacol. 2016 Aug;79:142-143. doi: 10.1016/j.yrtph.2016.03.001. Epub 2016 Mar 4. No abstract available.

PMID:
26952647
35.

A novel biclustering algorithm of binary microarray data: BiBinCons and BiBinAlter.

Saber HB, Elloumi M.

BioData Min. 2015 Nov 30;8:38. doi: 10.1186/s13040-015-0070-4. eCollection 2015.

36.

Serum Leptin Levels and the Risk of Stroke: The Framingham Study.

Saber H, Himali JJ, Shoamanesh A, Beiser A, Pikula A, Harris TB, Roubenoff R, Romero JR, Kase CS, Vasan RS, Seshadri S.

Stroke. 2015 Oct;46(10):2881-5. doi: 10.1161/STROKEAHA.115.009463. Epub 2015 Sep 3.

37.

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.

de Claro RA, McGinn KM, Verdun N, Lee SL, Chiu HJ, Saber H, Brower ME, Chang CJ, Pfuma E, Habtemariam B, Bullock J, Wang Y, Nie L, Chen XH, Lu DR, Al-Hakim A, Kane RC, Kaminskas E, Justice R, Farrell AT, Pazdur R.

Clin Cancer Res. 2015 Aug 15;21(16):3586-90. doi: 10.1158/1078-0432.CCR-14-2225.

39.

Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation.

Ghayour-Mobarhan M, Moohebati M, Esmaily H, Ebrahimi M, Parizadeh SM, Heidari-Bakavoli AR, Safarian M, Mokhber N, Nematy M, Saber H, Mohammadi M, Andalibi MS, Ferns GA, Azarpazhooh MR.

Int J Public Health. 2015 Jul;60(5):561-72. doi: 10.1007/s00038-015-0679-6. Epub 2015 May 6.

PMID:
25943424
40.

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma.

Lee HZ, Kwitkowski VE, Del Valle PL, Ricci MS, Saber H, Habtemariam BA, Bullock J, Bloomquist E, Li Shen Y, Chen XH, Brown J, Mehrotra N, Dorff S, Charlab R, Kane RC, Kaminskas E, Justice R, Farrell AT, Pazdur R.

Clin Cancer Res. 2015 Jun 15;21(12):2666-70. doi: 10.1158/1078-0432.CCR-14-3119. Epub 2015 Mar 23.

41.

An FDA oncology analysis of antibody-drug conjugates.

Saber H, Leighton JK.

Regul Toxicol Pharmacol. 2015 Apr;71(3):444-52. doi: 10.1016/j.yrtph.2015.01.014. Epub 2015 Feb 7.

PMID:
25661711
42.

FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma.

Miller BW, Przepiorka D, de Claro RA, Lee K, Nie L, Simpson N, Gudi R, Saber H, Shord S, Bullock J, Marathe D, Mehrotra N, Hsieh LS, Ghosh D, Brown J, Kane RC, Justice R, Kaminskas E, Farrell AT, Pazdur R.

Clin Cancer Res. 2015 Apr 1;21(7):1525-9. doi: 10.1158/1078-0432.CCR-14-2522. Epub 2015 Feb 2.

43.

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease.

Deisseroth A, Ko CW, Nie L, Zirkelbach JF, Zhao L, Bullock J, Mehrotra N, Del Valle P, Saber H, Sheth C, Gehrke B, Justice R, Farrell A, Pazdur R.

Clin Cancer Res. 2015 Mar 1;21(5):950-4. doi: 10.1158/1078-0432.CCR-14-1678. Epub 2015 Jan 19. Review.

44.

Insulin-like growth factor-1 as a predictor of mortality in frail Egyptian elderly adults.

Amer MS, Farid TM, Farid HM, Mabrouk RA, Saber HG.

J Am Geriatr Soc. 2014 Oct;62(10):2001-2. doi: 10.1111/jgs.13059. No abstract available.

PMID:
25333546
45.

Inflammatory markers in frail elderly Egyptian adults and the difference between the sexes.

Amer MS, Farid TM, Wahba HM, Saber HG, Abdelwahab RR.

J Am Geriatr Soc. 2014 Jul;62(7):1400-2. doi: 10.1111/jgs.12896. No abstract available.

PMID:
25039519
46.

U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemia.

Lee HZ, Miller BW, Kwitkowski VE, Ricci S, DelValle P, Saber H, Grillo J, Bullock J, Florian J, Mehrotra N, Ko CW, Nie L, Shapiro M, Tolnay M, Kane RC, Kaminskas E, Justice R, Farrell AT, Pazdur R.

Clin Cancer Res. 2014 Aug 1;20(15):3902-7. doi: 10.1158/1078-0432.CCR-14-0516. Epub 2014 May 13.

47.

Evaluation of serum interleukins-6, 8 and 10 levels as diagnostic markers of neonatal infection and possibility of mortality.

Boskabadi H, Maamouri G, Tavakol Afshari J, Mafinejad S, Hosseini G, Mostafavi-Toroghi H, Saber H, Ghayour-Mobarhan M, Ferns G.

Iran J Basic Med Sci. 2013 Dec;16(12):1232-7.

49.

U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia.

Alvandi F, Kwitkowski VE, Ko CW, Rothmann MD, Ricci S, Saber H, Ghosh D, Brown J, Pfeiler E, Chikhale E, Grillo J, Bullock J, Kane R, Kaminskas E, Farrell AT, Pazdur R.

Oncologist. 2014 Jan;19(1):94-9. doi: 10.1634/theoncologist.2013-0077. Epub 2013 Dec 5.

50.

Prooxidant-antioxidant balance in perinatal asphyxia.

Boskabadi H, Navaee Boroujeni A, Mostafavi-Toroghi H, Hosseini G, Ghayour-Mobarhan M, Hamidi Alamdari D, Biranvandi M, Saber H, Ferns GA.

Indian J Pediatr. 2014 Mar;81(3):248-53. doi: 10.1007/s12098-013-1239-9. Epub 2013 Oct 22.

PMID:
24146060

Supplemental Content

Support Center